ARTICLES:
Disease Reporting Notes
For an explanation of the Homeland Security Advisory System and recommendations
from the US Dept of Homeland Security and the American Red Cross on recommended
activities at each level,
click here.
Olathe:
11875 S. Sunset Dr.
Suite 300
Olathe, KS 66061
PH: 913.894.2525
FX: 913.477.8048
Mission:
6000 Lamar
Suite 140
Mission, KS 66202
PH: 913.826.1200
FX: 913.826.1210
On September 25, 2009, the Johnson County Health Department confirmed that one resident of the county had died from H1N1 infection, bringing the current state total to six deaths. Total influenza hospitalization rates for adults and children are similar to or lower than seasonal influenza hospitalization rates depending on age group, but are higher than expected for this time of year. There have been 82 H1N1-related hospitalizations in Kansas so far during the pandemic.
H1N1 vaccine should be arriving in early October at the Health Departments in Kansas. Kansas will receive 50 to 60 thousand doses of nasal-spray Flu Mist in early October. The Flu Mist version of the vaccine is suitable for healthy individuals two to 49 years of age. It is not recommended for those individuals with underlying medical conditions or for pregnant women. Vaccines in injectable form are likely to be available in mid-October.
Priority groups for vaccination are:
• Pregnant women
• People who live with or provide care for infants younger than age six months (parents, siblings, daycare providers)
• Healthcare and emergency medical services personnel
• Children and young adults ages six months through 24 years
• People ages 25 to 64 years of age who have medical conditions that put them at increased risk for influenza-related complications
KDHE has transitioned to new testing procedures for the H1N1 virus and is no longer accepting specimens from everyone who presents to a doctor with symptoms. KDHE will continue collecting specimens from hospitalized patients, as well as a limited number of specimens from clinics and hospitals across the state that are submitting weekly information on the number of patients they are seeing with flu‐like symptoms.
As with any influenza virus, individuals are encouraged to take the following steps to reduce spread:
• Wash your hands thoroughly with soap and warm water or use an alcohol‐based hand sanitizer to get rid of most germs and avoid touching your eyes, nose, and mouth.
• Stay home when you are sick to avoid spreading illness to co‐workers and friends.
• Cough or sneeze into your elbow or a tissue and properly dispose of used tissue.
• Stay healthy by eating a balanced diet, drinking plenty of water and getting adequate rest and exercise.
Disease Name
|
Jan
09 |
Feb
09 |
Mar
09 |
April
09 |
May
09 |
June
09 |
July
09 |
Aug
09 |
Total
YTD |
Campylobacter Infection
(Campylobacter spp.)
|
2
|
3
|
8
|
4
|
4
|
8
|
9
|
8 |
46
|
Cryptosporidiosis (Cryptosporidium parvum)
|
0
|
0
|
1
|
2
|
3
|
1
|
3
|
2 |
12
|
Enterohemorrhagic Escherichia coli shiga toxin positive (not serogrouped)
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
1 |
3
|
Enterohemorrhagic Escherichia coli shiga toxin positive (serogroup non-O157)
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2 |
4
|
Enterohemorrhagic Escherichia coli 0157:H7
|
0
|
0
|
0
|
1
|
1
|
0
|
2
|
0 |
4
|
Giardiasis (Giardia lamblia)
|
1
|
3
|
2
|
2
|
1
|
3
|
0
|
4 |
16
|
Salmonellosis (Salmonella spp.)
|
2
|
2
|
3
|
2
|
2
|
6
|
5
|
7 |
29
|
Shigellosis (Shigella spp.)
|
1
|
2
|
1
|
1
|
1
|
2
|
1
|
4 |
13
|
Amebiasis (Entamoeba histolytica)
|
0
|
0
|
0
|
2
|
1
|
0
|
1
|
0 |
4
|
Brucellosis
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1 |
3
|
Ehrlichiosis, Ehrlichia chaffeensis
|
0
|
1
|
1
|
0
|
1
|
6
|
3
|
8 |
20
|
Ehrlichiosis, human other
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
0 |
3
|
Hepatitis A
|
1
|
4
|
3
|
1
|
3
|
5
|
4
|
12 |
33
|
Hepatitis B, acute
|
1
|
0
|
0
|
1
|
1
|
2
|
1
|
0 |
6
|
Hepatitis B, chronic
|
7
|
10
|
10
|
5
|
13
|
12
|
7
|
8 |
72
|
Hepatitis C virus infection (past or present)
|
21
|
14
|
12
|
18
|
19
|
21
|
13
|
17 |
135
|
Legionellosis
|
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0 |
2
|
Lyme Disease (Borrelia burgdorferi)
|
1
|
1
|
1
|
2
|
6
|
4
|
15
|
15 |
45
|
Malaria (Plasmodium spp.)
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0 |
1
|
Meningitis, Niesseria meningitidis
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0 |
1
|
Meningitis, other bacterial
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0 |
2
|
Q Fever (Coxiella burnetii)
|
0
|
1
|
1
|
1
|
0
|
0
|
0
|
0 |
3
|
Rocky Mountain Spotted Fever (Rickettsia rickettsii) (RMSF)
|
3
|
2
|
1
|
3
|
3
|
8
|
6
|
11 |
37
|
Streptococcal Disease, Invasive, Group A (Streptococcus pyogenes)
|
0
|
5
|
1
|
3
|
2
|
3
|
0
|
0 |
14
|
Streptococcus pneumoniae, invasive, drug-resistant
|
2
|
2
|
2
|
2
|
0
|
2
|
1
|
2 |
13
|
Toxic Shock Syndrome, streptococcal and staphylococcal
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0 |
2
|
Transmissable Spongioform Encephalitis (TSE./CJD) |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
Tularemia |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
1 |
1 |
Haemophilus influenzae, invasive
|
0
|
0
|
1
|
1
|
0
|
1
|
0
|
1 |
4
|
Measles
|
0
|
0
|
0
|
0
|
0
|
1
|
1 |
0 |
2
|
Mumps
|
1
|
0
|
2
|
2
|
2
|
1
|
0
|
0 |
8
|
Pertussis (Bordetella pertussis) (Whooping cough)
|
6
|
9
|
7
|
7
|
1
|
8
|
10
|
16 |
64
|
Varicella (Chickenpox)
|
13
|
23
|
22
|
27
|
14
|
8
|
2
|
6 |
115
|
Early Syphilis
|
2
|
4
|
1
|
1
|
0
|
1
|
0
|
0 |
9
|
Gonorrhea
|
5
|
25
|
18
|
9
|
8
|
20
|
11
|
7 |
103
|
Chlamydia
|
61
|
176
|
80
|
118
|
96
|
37
|
127
|
4 |
699
|
Latent Tuberculosis infection
|
20
|
29
|
34
|
23
|
24
|
34
|
18
|
21 |
203 |
Active Tuberculosis infection
|
2
|
5
|
7
|
0
|
0
|
4
|
6
|
10 |
34
|
This includes the number of reported cases investigated by JCHD (case classifications include: confirmed, probable, suspect, not a case.)
Disease
Reporting Notes:
If you have any questions about the monthly Epi Update, or any other disease surveillance or containment questions,
please contact Nancy Tausz, RN, BSN, Director of the Disease Containment
Division, at (913) 826-1222 or by email at: Nancy.Tausz@jocogov.org.
Communicable disease reporting is the cornerstone of public health surveillance and disease control. Please remember to maintain an index of suspicion for bioterrorism and reportable disease, and give the Disease Containment staff a call if you have any questions or concerns at (913) 826-1303. On behalf of the Johnson County Health Department, thank you for your continued support.
Johnson County government does not discriminate on the basis of race, color, national origin, gender, religion, age and handicapped status in employment or the provision of programs and services.
DISEASE REPORTING
Outbreaks, unusual occurrences of any disease,
and suspect acts of terrorism are required by state law (K.S.A. 65-118) to
be immediately reported to the Kansas Department of Health and Environment
24-hour hotline:
1-877-427-7317
For routine reporting of reportable diseases, notify
the Johnson County Health Department Disease Containment Program.
Tel: (913) 826-1303
Fax: (913) 826-1210
